A Study of ASP3082 in Combination With Chemotherapy in People With Pancreatic Cancer

Full Title

A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of ASP3082 in Combination with mFOLFIRINOX or NALIRIFOX as First-line Treatment in Participants with KRAS G12D-mutated Metastatic Pancreatic Adenocarcinoma

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Wungki Park’s office at 646-888-4543.

Protocol
26-211
Phase
Phase III (phase 3)
Investigator
Wungki Park
Co-Investigators
Eileen M. O'Reilly
Diseases
Hepatobiliary › Pancreatic Cancer
Upper Gastrointestinal › Pancreatic Cancer
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07409272
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description